logo

For the Inventor, By the Inventor

Taejon, South Korea

Dong Il Han

This inventor holds 7 USPTO granted patents. Top assignees: Yukong Limited, Sk Corporation. Active years: 1997-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dong Il Han. Retrieved from https://idiyas.com/inventor/dong-il-han-9bd9tlb8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 206(Granted Patents)


Location History:

  • Taejon, KR (1997 - 1999)
  • Yusung-ku, KR (1997 - 2000)

Company Filing History:

goldMedal6 out of 34 
 
Yukong Limited
 patents
silverMedal1 out of 63 
 
Sk Corporation
 patents

Years Active: 1997-2000

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6140532 - O-carbamoyl-phenylalaninol having substituent at benzene ring, its (2000-10-31),
2. 5892088 - Sulfamate compound containing N-substituted carbamoyl group and method (1999-04-06),
3. 5849772 - Carbamate compounds and processes for preparing the same (1998-12-15),
4. 5756817 - O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful (1998-05-26),
5. 5705640 - O-carbamoyl-(d)-phenylalaninol compounds, their pharmaceutically useful (1998-01-06),
6. 5654461 - Sulfamate compound containing carbamoyl group (1997-08-05),
7. 5627300 - Carbamate compounds containing thiocarbamoyl group and process for (1997-05-06),

Title: The Innovations of Dong Il Han

Introduction

Dong Il Han is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of central nervous system disorders. With a total of seven patents to his name, his work has garnered attention in both academic and industrial circles.

Latest Patents

Among his latest patents, Dong Il Han has developed O-carbamoyl-phenylalaninol, which features a substituent at the benzene ring. This compound, along with its pharmaceutically useful salts, is designed for the prophylaxis and treatment of CNS disorders, including depression and anxiety. The general formula for this compound includes various substituents such as lower alkyl groups, halogens, and alkoxy groups. Additionally, he has disclosed novel sulfamate compounds containing N-substituted carbamoyl groups, which are also aimed at treating CNS disorders, particularly nervous myalgia, epilepsy, and minimal brain dysfunction.

Career Highlights

Throughout his career, Dong Il Han has worked with prominent companies such as Yukong Limited and SK Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in the field.

Collaborations

Dong Il Han has collaborated with notable colleagues, including Yong Moon Choi and Hyung Cheol Kim. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Dong Il Han's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of CNS disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…